Publication | Closed Access
Abatacept in monotherapy<i>vs</i>combined in interstitial lung disease of rheumatoid arthritis—multicentre study of 263 Caucasian patients
33
Citations
36
References
2021
Year
In Caucasian individuals with RA-ILD, ABA in monotherapy or combined with MTX or with other conventional-DMARDs seems to be equally effective and safe. However, a CS-sparing effect is only observed with combined ABA.
| Year | Citations | |
|---|---|---|
Page 1
Page 1